Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
News|Articles|May 12, 2022
Shingrix: Who Needs It and Who Doesn't?
Author(s)Terry Brenneman, MD
Advertisement
Shingrix, the only shingles vaccine now available, is recommended for routine use in adults aged ≥50 years. As with most vaccines, exceptions always seem to exist, complicating the decision-making. As they say, the devil is in the details. Let's see how “devilish” you are today, with the 4-question quiz below.
1. A 40-year-old woman with no history of varicella disease thinks she received the vaccine as a child, but no records are available. She has been diagnosed with cancer and will be starting chemotherapy in 1-2 weeks. Since immunocompromised patients are at increased risk of shingles and its complications, should this woman start her 2-dose Shingrix series?
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Patient Care Online
1
Menopause Hormone Therapy Linked to Greater Weight Loss With Semaglutide in Real-World Study
2
Menopause Diagnoses Documented in Just 7.8% of Midlife Women's Outpatient Visits, Study Finds
3
Fezolinetant May Improve Depression, Anxiety Symptoms in Women With Menopausal VMS
4
Safety Monitoring and Dosing for NK3 Antagonists in Menopause VMS
5